Cargando…
Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
PURPOSE: To develop and validate a radiomics nomogram for the prediction of clinically significant prostate cancer (CsPCa) in Prostate Imaging-Reporting and Data System (PI-RADS) category 3 lesions. METHODS: We retrospectively enrolled 306 patients within PI-RADS 3 lesion from January 2015 to July 2...
Autores principales: | Li, Tianping, Sun, Linna, Li, Qinghe, Luo, Xunrong, Luo, Mingfang, Xie, Haizhu, Wang, Peiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825569/ https://www.ncbi.nlm.nih.gov/pubmed/35155214 http://dx.doi.org/10.3389/fonc.2021.825429 |
Ejemplares similares
-
Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
por: Jin, Pengfei, et al.
Publicado: (2022) -
Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer
por: Li, Mou, et al.
Publicado: (2021) -
Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram
por: Jing, Guodong, et al.
Publicado: (2022) -
MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
por: Chen, Tong, et al.
Publicado: (2022) -
Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm
por: Lin, Fan, et al.
Publicado: (2020)